statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Titoli in rialzo
Il titolo Evoke Pharma (NASDAQ:EVOK) ha osservato un incremento del 41,47% a 0,75 dollari durante la sessione pre-market di mercoled .
Le azioni di Jaguar Health (NASDAQ:JAGX) sono...

12 titoli sanitari in movimento, pre-market del 10/04/2024

StockNews.com started coverage on shares of Evoke Pharma (NASDAQ:EVOK - Free Report) in a report issued on Tuesday. The firm issued a sell rating on the specialty pharmaceutical company's stock...

StockNews.com Begins Coverage on Evoke Pharma (NASDAQ:EVOK)

StockNews.com assumed coverage on shares of Evoke Pharma (NASDAQ:EVOK - Free Report) in a research report sent to investors on Tuesday morning. The firm issued a sell rating on the specialty...

Evoke Pharma (NASDAQ:EVOK) Now Covered by Analysts at StockNews.com

SOLANA BEACH, Calif., March 21, 2024 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) diseases...

Evoke Pharma Announces Senior Leadership Transition with Promotion of Matthew J. D'Onofrio to Chief Executive Officer

StockNews.com started coverage on shares of Evoke Pharma (NASDAQ:EVOK  Free Report) in a report published on Sunday morning. The brokerage issued a sell rating on the specialty pharmaceutical...

Q4 2023 Evoke Pharma Inc Earnings Call Transcript

Evoke Pharma GAAP EPS of -$0.59 revenue of $1.7M...

Evoke Pharma GAAP EPS of -$0.59  revenue of $1.7M

Evoke Pharma, Inc.

 Balance Sheet

 Evoke Pharma, Inc.

 Statement of Operations

Fiscal year 2023 net product sales from prescriptions totaled approximately...

Evoke Pharma Reports Fourth Quarter and Full Year 2023 Financial Results

Gagnants
Le titre Molina Healthcare (NYSE:MOH) a grimp mercredi de 24,25% 503,11 dollars lors de la session after-market.
L'action Evoke Pharma (NASDAQ:EVOK) a grimp de 18,54% 0,76...

12 titres de soins de sant  en mouvement lors de la session apr s-cl ture le 13/03/2024

Titoli in rialzo
Le azioni di Molina Healthcare (NYSE:MOH) hanno fatto segnare +24,25% a 503,11 dollari durante la sessione after-market di mercoled .
Il titolo Evoke Pharma (NASDAQ:EVOK) ha...

12 titoli sanitari in movimento, after-market del 13/03/2024

Evoke Pharma, Inc. is a pharmaceutical company, which engages in the development of drugs for the treatment of gastrointestinal disorders and diseases. It also develops Gimoti, with promotility and anti-emetic effects, for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women with diabetes mellitus. The company was founded by Matthew J. D'Onofrio, Cam L. Garner, Scott L. Glenn, and David A. Gonyer in January 2007 and is headquartered in Solana Beach, CA.

Watchers	12,031
52-Wk Low	$0.4104
52-Wk High	$2.16

Volume	29,292.00
52-Wk High	$2.16
52-Wk Low	$0.4104

Period	Estimated	Reported	Surprise	Result
Q1'24	-$0.21	--	--	N/A
Q4'23	-$0.50	-$0.59	-18.00%	MISSED
Q3'23	-$0.62	-$0.51	17.74%	BEAT
Q2'23	-$0.73	-$0.56	23.29%	BEAT
Q1'23	-$0.58	-$0.67	-15.52%	MISSED

EVOK Evoke Pharma Inc

About

Feed

News

Sentiment

Earnings

Fundamentals